Legal & General Group plc isn’t the only dividend king I’d buy today

Harvey Jones says that Legal & General Group plc (LON: LGEN) is a long-standing favourite and picks out another insurer with premium potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Insurance giant Legal & General Group (LSE: LGEN) has been one of my favourite FTSE 100 stocks for years and it has more than justified my admiration. Its share price is up 92% over five years and 38% over 12 months, after shrugging off shocks such as the impact of pension freedom reforms on annuity sales.

Legal matters

Even better, L&G currently yields a juicy 5.31%, making it one of the most attractive income and growth stocks around. I would buy it yesterday, I would buy it today and I would buy it tomorrow. I see plenty of upside ahead but this isn’t the only insurance company on my shopping list.

RSA Insurance Group (LSE: RSA) has had a mixed time of it lately, and this is reflected in its stock performance. It trades just 25% higher than five years ago although it has been showing signs of greater urgency lately, rising 28% in the past 12 months. It has taken a knock today, falling around 2.25% on publication of its Q3 trading update.

Storm warning

This dip has mildly surprised me given that the report has been broadly welcomed by analysts. Its brief trading update showed an 8% increase in net written premiums to £5.077bn year-to-date, or 3% at constant exchange rates. Earnings per share (EPS) are ahead of last year but behind target.

The group’s underwriting performance was hit by the extreme Caribbean hurricane season, but sweep that aside and it is clear that underlying performance continues to improve. Premiums grew 5% in the UK, 8% in Scandinavia and 16% in Canada, with only Ireland disappointingly flat. The UK household insurance market is tough at the moment, but the group is taking action to mitigate that.

Write on

Group CEO and turnaround titan Stephen Hester said profits are ahead of the same period in 2016, although by less than targeted. We are continuing to drive business enhancements across the group, whilst taking further underwriting action in some portfolios to improve performance for 2018.”

City analysts are upbeat, predicting 8% earnings per share (EPS) growth in 2017 then another 21% in 2018. Its forecast dividend yield is 3.4% but nicely covered two times, giving scope for generous progression. By 2018, the yield is expected to hit 4.5%, making it a great dividend stock. Trading at a forecast 15 times earnings, today’s dip looks like a buying opportunity to me.

Generally speaking

RSA is a general insurance specialist and a very different beast to L&G, which has a massive investment management arm, and it presciently made the move into low-cost index trackers before ETFs ruled the world. It recently posted a 43% leap in first-half profits after tax to £952m and hiked its interim dividend 7.5% from 4p per share to 4.3p, in line with its stated policy of paying 30% of the previous year’s total dividend.

There will inevitably be bumps in the road after five consecutive years of double-digit EPS growth. Another 13% increase is forecast for 2017, but then a 2% dip in 2018. I would view any slippage as a buying opportunity although trading at a forecast 10.7 times earnings I would buy it today. 

L&G is vulnerable to a stock market downturn, RSA is vulnerable to the weather. This means they do not correlate and could therefore balance each other quite nicely.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »